We are live on ! Find out more
CMRX

Chimerix, Inc.

Delisted

CMRX was delisted on the 17th of April, 2025.

117 hedge funds and large institutions have $99.2M invested in Chimerix, Inc. in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

576% more call options, than puts

Call options by funds: $581K | Put options by funds: $86K

14% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 35

6% less funds holding

Funds holding: 125117 (-8)

22% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 27

59% less capital invested

Capital invested by funds: $240M → $99.2M (-$141M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
117
Holders Change
-8
Holders Change %
-6.4%
% of All Funds
1.97%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
21
Increased
40
Reduced
35
Closed
27
Calls
$581K
Puts
$86K
Net Calls
+$495K
Net Calls Change
-$539K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
51
UBS Group
Switzerland
$142K -$627K -195,104 -74%
B
52
Bailard
California
$142K +$219K +68,100 New
DY
53
Dowling & Yahnke
California
$133K +$32.1K +10,000 +18%
VF
54
Virtu Financial
New York
$128K +$154K +48,020 +357%
CHAM
55
Clear Harbor Asset Management
Connecticut
$127K +$146K +45,500 +294%
CANY
56
Caxton Associates (New York)
New York
$123K +$189K +58,898 New
Legal & General Group
57
Legal & General Group
United Kingdom
$115K +$5.13K +1,598 +3%
BFM
58
Boothbay Fund Management
New York
$108K -$106K -32,880 -39%
JP Morgan Chase
59
JP Morgan Chase
New York
$107K +$13.5K +4,209 +9%
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$104K -$543 -169 -0.3%
Ameriprise
61
Ameriprise
Minnesota
$99K +$74.5K +23,211 +95%
AIG
62
American International Group
New York
$82K +$10.2K +3,166 +9%
Simplex Trading
63
Simplex Trading
Illinois
$78K +$111K +34,712 +1,204%
Deutsche Bank
64
Deutsche Bank
Germany
$77K -$16.2K -5,038 -12%
XT
65
XTX Topco
Cayman Islands
$77K +$119K +37,091 New
VOYA Investment Management
66
VOYA Investment Management
Georgia
$72K +$17K +5,289 +18%
Group One Trading
67
Group One Trading
Illinois
$71K -$42.9K -13,360 -28%
Bank of America
68
Bank of America
North Carolina
$70K -$384K -119,588 -78%
JIC
69
Joel Isaacson & Co
New York
$70K
Invesco
70
Invesco
Georgia
$66K -$135 -42 -0.1%
BNP Paribas Financial Markets
71
BNP Paribas Financial Markets
France
$65.2K +$77.4K +24,091 +331%
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$63K
HighTower Advisors
73
HighTower Advisors
Illinois
$62K
Franklin Resources
74
Franklin Resources
California
$58K -$43.3K -13,490 -33%
EMG
75
ETF Managers Group
New Jersey
$57K +$3.94K +1,226 +5%

CMRX Hedge Fund Activity: Q2 2022 in Review

117 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q2 2022, worth a combined $99.2M — down 59% from $240M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of CMRX and 21 opened new positions — a net loss of 6 holders — while 35 trimmed existing stakes and 40 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $11.3M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $19.2M sold.

  • 117 institutional investors held Chimerix, Inc. (CMRX) as of Q2 2022, down from 125 in Q1 2022.
  • Funds reported $99.2M of Chimerix, Inc. stock for Q2 2022, down 59% quarter-over-quarter.
  • 21 funds opened new Chimerix, Inc. positions in Q2 2022 and 27 closed out, a net change of -6 holders.
  • The largest Chimerix, Inc. buyer in Q2 2022 was Armistice Capital, an estimated $11.3M added.
  • The largest Chimerix, Inc. seller in Q2 2022 was Point72 Asset Management, an estimated $19.2M sold.

Based on aggregated 13F filings for Q2 2022.